Wnt activator FOXB2 drives prostate cancer neuroendocrine differentiation
L. Moparthi, G. Pizzolato, S. Koch
This study identifies FOXB2 as a Wnt activator that drives neuroendocrine differentiation in prostate cancer and is associated with poor recurrence-free survival.
bioRxiv · Mar 3, 2019Cancer Biology